Loading…
Non-Prescription Drug Modernization Act of 2007
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (16)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2009 · first_quarter · Health Issues
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 759
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Health Issues
Non-Prescription Drug Modernization Act - H.R.4083, S.2317 FDA Globalization Act - H.R.759 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Health Issues
Non-Prescription Drug Modernization Act - H.R.4083, S.2317 FDA Globalization Act - H.R.759
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Health Issues
Non-Prescription Drug Modernization Act - H.R. 4083, S. 2317 FDA Globalization Act - H.R. 759
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Health Issues
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 759
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| CA |
| Steve Cohen | Democratic | TN |
| Thomas Allen | Democratic | ME |
2009 · first_quarter · Health Issues
HR 4703, S 2467, HR 4991 - Vaccine Shortage preparedness Act of 2008 S 2464, HR 4992, HR 4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare Part B S 2465 - Vaccines for Children Access Act of 2008 HR 2 - Children's Health Insurance Program Reauthorization Act of 2009 S 75 - Generics First Act 2009 S 80 - Importation of Prescription Drugs S 301 - Physician Payments Sunshine Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals HR 5839 - Safeguarding America's Pharmaceuticals Act of 2008 S 3408 - Comparative Effectiveness Research Act of 2008 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 S 2467 - Vaccine shortage preparedness Act of 2008 S 3678 - /PL 109-417 All pandemic and all-hazards act - Section 317 program issues HR 970 and S 1378 - Dextromethorphan Distribution Act of 2007 S 103 - Combat Meth Act of 2005 HR 2207 - Agricultural Disaster Assistance and Western States Emergency - Unfinished business Appropriations Act of 2007 HR 1908 and S 1710 Patent Reform Act of 2007 HR 1 - Implementing the 9/11 Commission recommendations Act of 2007 HR 3162 - Children's Health and Medicare Protection Act of 2007 S 1505 - Affordable Biologics for Consumers Act S 1695 - Biologics Price Competition and Innovation Act of 2007 HR 1956 - Patent Protection and Innovative Biologic Medicines Act of 2007 HR 1038, S623 - Access to Life-Saving Medicine Act HR 4083 - Non-prescription Drug Modernization Act of 2007 HR 1308 - Legal Immigrant Children's Health Improvement Act of 2007 HR 5629 - Pathway for Biosimilars Act HR 1427 - To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes S 726 - A bill to amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes Comparative Effectiveness Research Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension
Client expense: $1,347,134 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)
2008 · fourth_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Health Issues
HR 4083, S 2311, non-prescription Drug Act of 2007; determining how to update and improve FDA regulation of OTC drugs
Client expense: Not reported · Firm income: $5,000
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Communications/Broadcasting/Radio/TV
S 234, Wireless Innovation Act HR 1597, Wireless Innovation Act S 337, White Spaces Act of 2007 S 602 Child Safe Viewing Act HR 2102, Free Flow Information Act of 2007 S 215, Internet Freedom Preservation Act HR 2738, Family and Consumer Choice Act HR 2821, Television Freedom Act of 2007 HR 2566, National Digital Television Consumer Education Act HR 2905, Broadcast Freedom Act of 2007 HR 608 Digital Television Consumer Education Act of 2007 HR 1320, Interference Protection for Existing Television Band Devices S 1780, Protecting Children from Indecent Programming Act HR 2900, Food and Drug Administration Act Amendments of 2007 S 1082, Food and Drug Administration Act Amendments of 2007 HR 2331 First Responders Act S 1223, First Responders Act China Market Access S2035 Free Flow Information Act HR 2566 Media Ownership Act S 2332 Media Ownership Act HR 3559 Protecting Children from Indecent Programming S1267, Free Flow Information Act of 2007 S2831, FTC Reauthorization Act S1170, "Connect the Nation Act" HR 3627, "Connect the Nation Act" HR 3862, Preparing America's Seniors for Digital Transition HR 5435, DTV Border Fix S 2507, DTV Border Fix Retransmission consent Product Placement a la carte HR 2905, Fairness Doctrine Fiscal Year 2009 Appropriations Mark HR 6209, Commercial Ads Loudness Mitigation Act S 3154, Commercial Ads Loudness Mitigation Act S 3156, Commercial Ads Loudness Mitigation Act DOJ to adopt new rules governing access under ADA for close captioning/video description in movies HR 6320, On Line Captioning HR 2320, National Amusement Park Ride Safety Act Broadband deployment provisions of Stimulus II HR 6151 Responsibility in Drug and Device Advertising Act of 2008 HR 4083 Non Prescription Drug Modernization Act S 3446 Bill to Create Minority Tax Credits HR 7013 Short Term Analog Flash and Emergency Readiness Act S 3663 Short Term Analog Flash and Emergency Readiness Act
Client expense: $4,260,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Natl Aeronautics & Space Administration (NASA), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2008 · fourth_quarter · Health Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Communications/Broadcasting/Radio/TV
S 234, Wireless Innovation Act HR 1597, Wireless Innovation Act S 337, White Spaces Act of 2007 S 602 Child Safe Viewing Act HR 2102, Free Flow Information Act of 2007 S 215, Internet Freedom Preservation Act HR 2738, Family and Consumer Choice Act HR 2821, Television Freedom Act of 2007 HR 2566, National Digital Television Consumer Education Act HR 2905, Broadcast Freedom Act of 2007 HR 608 Digital Television Consumer Education Act of 2007 HR 1320, Interference Protection for Existing Television Band Devices S 1780, Protecting Children from Indecent Programming Act HR 2900, Food and Drug Administration Act Amendments of 2007 S 1082, Food and Drug Administration Act Amendments of 2007 HR 2331 First Responders Act S 1223, First Responders Act China Market Access S2035 Free Flow Information Act HR 2566 Media Ownership Act S 2332 Media Ownership Act HR 3559 Protecting Children from Indecent Programming S1267, Free Flow Information Act of 2007 S2831, FTC Reauthorization Act S1170, "Connect the Nation Act" HR 3627, "Connect the Nation Act" HR 3862, Preparing America's Seniors for Digital Transition HR 5435, DTV Border Fix S 2507, DTV Border Fix Retransmission consent Product Placement a la carte HR 2905, Fairness Doctrine Fiscal Year 2009 Appropriations Mark HR 6209, Commercial Ads Loudness Mitigation Act S 3154, Commercial Ads Loudness Mitigation Act S 3156, Commercial Ads Loudness Mitigation Act DOJ to adopt new rules governing access under ADA for close captioning/video description in movies HR 6320, On Line Captioning HR 2320, National Amusement Park Ride Safety Act Broadband deployment provisions of Stimulus II HR 6151 Responsibility in Drug and Device Advertising Act of 2008 HR 4083 Non Prescription Drug Modernization Act S 3446 Bill to Create Minority Tax Credits HR 7013 Short Term Analog Flash and Emergency Readiness Act S 3663 Short Term Analog Flash and Emergency Readiness Act
Client expense: $4,260,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Natl Aeronautics & Space Administration (NASA), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2008 · fourth_quarter · Health Issues
Pediatric Cough and Cold Medicines Regulation and Advertising of OTC's, HR 4083 and S. 2311 HR 6151, Direct to Consumer Advertising of Drugs
Client expense: $65,235 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisements
Client expense: $260,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 3610, S 3409
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 4703, S 2467, HR 4991 - Vaccine Shortage preparedness Act of 2008 S 2464, HR 4992, HR 4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare Part B S 2465 - Vaccines for Children Access Act of 2008 HR 5839 - Safeguarding America's Pharmaceuticals Act of 2008 S 3408 - Comparative Effectiveness Research Act of 2008 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 S 2467 - Vaccine shortage preparedness Act of 2008 S 3678 - /PL 109-417 All pandemic and all-hazards act - Section 317 program issues HR 970 and S 1378 - Dextromethorphan Distribution Act of 2007 S 103 - Combat Meth Act of 2005 HR 2207 - Agricultural Disaster Assistance and Western States Emergency - Unfinished business Appropriations Act of 2007 HR 1908 and S 1710 Patent Reform Act of 2007 HR 1 - Implementing the 9/11 Commission recommendations Act of 2007 HR 3162 - Children's Health and Medicare Protection Act of 2007 S 1505 - Affordable Biologics for Consumers Act S 1695 - Biologics Price Competition and Innovation Act of 2007 HR 1956 - Patent Protection and Innovative Biologic Medicines Act of 2007 HR 1038, S623 - Access to Life-Saving Medicine Act HR 4083 - Non-prescription Drug Modernization Act of 2007 HR 1308 - Legal Immigrant Children's Health Improvement Act of 2007 HR 5629 - Pathway for Biosimilars Act Comparative Effectiveness Research Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension
Client expense: $1,340,838 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; HR 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisements
Client expense: $240,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 3610, S 3409
Client expense: Not reported · Firm income: $40,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,500,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
HR 4703, S 2467, HR 4991 - Vaccine Shortage preparedness Act of 2008 S 2464, HR 4992, HR 4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare Part B S 2465 - Vaccines for Children Access Act of 2008 HR 5839 - Safeguarding America's Pharmaceuticals Act of 2008 S 3408 - Comparative Effectiveness Research Act of 2008 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 S 2467 - Vaccine shortage preparedness Act of 2008 S 3678 - /PL 109-417 All pandemic and all-hazards act - Section 317 program issues HR 970 and S 1378 - Dextromethorphan Distribution Act of 2007 S 103 - Combat Meth Act of 2005 HR 2207 - Agricultural Disaster Assistance and Western States Emergency - Unfinished business Appropriations Act of 2007 HR 1908 and S 1710 Patent Reform Act of 2007 HR 1 - Implementing the 9/11 Commission recommendations Act of 2007 HR 3162 - Children's Health and Medicare Protection Act of 2007 S 1505 - Affordable Biologics for Consumers Act S 1695 - Biologics Price Competition and Innovation Act of 2007 HR 1956 - Patent Protection and Innovative Biologic Medicines Act of 2007 HR 1038, S623 - Access to Life-Saving Medicine Act HR 4083 - Non-prescription Drug Modernization Act of 2007 HR 1308 - Legal Immigrant Children's Health Improvement Act of 2007 HR 5629 - Pathway for Biosimilars Act Comparative Effectiveness Research Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension
Client expense: $1,377,211 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Pediatric Cough and Cold Medicines Regulation and Advertising of OTC's, HR 4083 and S. 2311 HR 6151 Direct to Consumer Advertising of Drugs
Client expense: $116,217 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Communications/Broadcasting/Radio/TV
S. 2311, H.R. 4083. Issues concerning advertising of over-the-counter medicines.
Client expense: $110,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
Concerning Pediatric Cough and Cold Medicines; Regulation of over-the-counter medicines. S. 2311 and H.R. 4083.
Client expense: $110,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR___, S____
Client expense: Not reported · Firm income: $40,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R.1561: To amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. H.R.2900: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. H.R.3580: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. H.R.4083: To amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes. S.1082: An act to amend the Federal Food, Drug, and cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products, and for other purposes. S.2311: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes.
Client expense: $3,130,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Natl Telecommunications & Information Administration (NTIA), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2008 · second_quarter · Health Issues
H.R.1585, National Defense Authorization Act for Fiscal Year 2008; H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; H.R.4083, Non-prescription Drug Modernization Act od 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.2331, Non-prescription Drug Modernization Act of 2007; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legisaltive proposals to extend federal contract prices to the retail section in the TRICARE program: H.R.1585, National Defense Authorization Act for Fiscal Year 2008; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legilsative proposals permitting importation of prescription drugs from overseas: H.R.2638, Department of Homeland Security Appropriations Act, 2008; H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; H.R.3162, Children's Health and Medicare Protection Act of 2007; S.242, Pharmaceutical Market Access and Drug Safety Act of 2007; S.1082, Food and Drug Administration Revitalization Act; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; SConRes.21, Concurrent resolution setting forth the congressional budget for the United States. Legislative proposals regarding drug safety, clinical trial registries, DTC adverstising, and reauthorization of the Prescription Drug User Fee Act, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act: H.R.2900, Food and Drug Administration Amendments Act of 2007; S.468, Food and Drug Administration Safety Act of 2007; S.484, Enhancing Drug Safety and Innovation Act of 2007; S.830, Pediatric Medical Device Safety and Improvement Act of 2007; S.993, Pediatric Research Improvement Act; S.1082, Food and Drug Administration Revitalization Act; S.1547, National Defense Authorization Act for Fiscal Year 2008. Legislative proposals regarding FDA funding: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative proposals to ensure access to meth-safe alternative medicines: H.R.3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008; S.1859, Agriculture, Rural Development , Food and Drug Administration, and Related Agencies Appropriations Act, 2008. Legislative propsals to reform the OTC monograph system: H.R.4083, Non-prescription Drug Modernization Act of 2007; S.2331, Non-prescription Drug Modernization Act of 2007. Response to congressional investigation regarding ENHANCE study.
Client expense: $530,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
Pediatric Cough and Cold Medicines; Regulation and Advertising of OTC's, H.R. 4083 and S. 2311 H.R. 6151 Direct to Consumer Advertising of Drugs
Client expense: $150,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
Food Advertising; Prescription Drug Advertising; Children's Advertising; S.334 Healthy Americans Act; S.484 Enhancing Drug Safety and Innovation Act of 2007; S.468 Food and Drug Administration Safety Act of 2007; HR 1561 Enhancing Drug Safety and Innovation Act of 2007; HR 2117 Health Freedom Protection Act; S 2311 Nonprescription Drug Modernization Act; HR 4083 Nonprescription Drug Modernization Act; S 100 Healthy Students Act of 2007; S 948 CAMRA Act; S. 1031; HR 2045; HR 2633;
Client expense: $75,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Pharmacy
H.R. 4083/S. 2311 Non-Prescription Drug Modernization Act of 2007; (Amending the FDCA, re: monographs and advertising.)
Client expense: $1,463,960 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE